FENNEC PHARMACEUTICALS INC. — Director's Dealing 2025

Feb 15, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FENNEC PHARMACEUTICALS INC. (FENC)
CIK: 0001211583
Period of Report: 2025-02-14

Reporting Person: RALLIS CHRIS A (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-02-14	Common Shares	M	1992	$2.51	Acquired	54206	Direct
2025-02-14	Common Shares	S	1186	$6.82	Disposed	53020	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-02-14	Common Shares	$2.51	M	1992	Disposed	2025-03-16	Options (1992)	Direct

Footnotes

F1: Shares acquired through the exercise of an option pursuant to a 10b5-1 plan adopted on August 17, 2023.

F2: Shares sold to satisfy tax obligation on option exercise.

F3: Represents options exercised pursuant to a 10b5-1 plan adopted on August 17, 2023.